1
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      Platelet glycoprotein IIb/IIIa blockade with tirofiban: effect on aggregation caused by P256, an antibody to human IIb/IIIa receptors.

      1 , ,
      British journal of clinical pharmacology

      Read this article at

      ScienceOpenPMC
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          P256 is a divalent antibody which aggregates human platelets by interaction with glycoprotein (GP) IIb/IIIa receptors. We investigated the effect of tirofiban, an antagonist of the GP IIb/IIIa receptor, on P256-mediated platelet aggregation.

          Related collections

          Author and article information

          Journal
          Br J Clin Pharmacol
          British journal of clinical pharmacology
          0306-5251
          0306-5251
          Aug 1999
          : 48
          : 2
          Affiliations
          [1 ] Merck Sharp and Dohme, Hoddesdon, Herts EN11 9BU, UK.
          Article
          bcp990
          2014294
          10417496
          acbd9bdb-fc87-4b9f-b0f1-32cd9b98a72d
          History

          Comments

          Comment on this article